This inventor holds 1 USPTO granted patent. Top assignees: Johns Hopkins University, Ustav Organicke Chemie a Biochemie Av Cr, V.v.i.. Active years: 2020.
Company Filing History:
1 out of 3,795 
1 out of 37 
Years Active: 2020
Title: Andrei Jancarik: Innovator in Cancer and Immunotherapy
Introduction
Andrei Jancarik is a notable inventor based in Koprivnice, Czech Republic. He has made significant contributions to the field of cancer treatment and immunotherapy. His innovative approaches focus on utilizing prodrugs of glutamine analogs to enhance therapeutic outcomes for patients.
Latest Patents
Andrei Jancarik holds a patent for "Methods for cancer and immunotherapy using prodrugs of glutamine analogs." This patent outlines methods for treating cancer in subjects, including those in remission, by administering a combination of immunotherapeutic agents and specific compounds that release glutamine analogs. The patent emphasizes the use of compounds that can effectively target cancer cells while minimizing side effects.
Career Highlights
Throughout his career, Jancarik has worked with esteemed institutions such as the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences and Johns Hopkins University. His work has been pivotal in advancing research in cancer therapies and immunology.
Collaborations
Andrei has collaborated with notable colleagues, including Jonathan David Powell and Lukas Tenora. These partnerships have fostered innovative research and development in the field of cancer treatment.
Conclusion
Andrei Jancarik's contributions to cancer and immunotherapy exemplify the impact of innovative thinking in medical science. His work continues to inspire advancements in treatment methodologies that could benefit countless patients.